Saigusa, et al.44(2011) evaluated 20 esophageal squamous cell carcinomas cases, following neoadjuvant chemoradiotherapy and found that cases with low expression of both podoplanin and SOX2 had a better prognosis. This evidence concerns the gene SOX2 and esophageal squamous cell carcinoma.